{
    "organizations": [],
    "uuid": "4a655082a12b5c62820053acdd9fd4a9efa85b62",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-catalyst-biosciences-announces-pro/brief-catalyst-biosciences-announces-proposed-public-offering-of-common-stock-idUSASB0C5AU",
    "ord_in_thread": 0,
    "title": "BRIEF-Catalyst Biosciences Announces Proposed Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 12 (Reuters) - Catalyst Biosciences Inc:\n* CATALYST BIOSCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* CATALYST BIOSCIENCES - ‍ANTICIPATES USING OFFERING PROCEEDS FOR PURPOSES INCLUDING CLINICAL & MANUFACTURING ACTIVITIES FOR CB 2679D, MARZEPTACOG ALFA​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-13T05:43:00.000+02:00",
    "crawled": "2018-02-13T15:30:34.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "catalyst",
        "bioscience",
        "inc",
        "catalyst",
        "bioscience",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "catalyst",
        "bioscience",
        "using",
        "offering",
        "proceeds",
        "purpose",
        "including",
        "clinical",
        "manufacturing",
        "activity",
        "cb",
        "2679d",
        "marzeptacog",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}